http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2807890-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e7a6f54f3b4e765aea9b6defac72db2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H7-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H7-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H7-02 |
| filingDate | 2012-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11ddda06d81e1ccc29f72b9b0d42afc1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03ee4622e84f831a339a41aef0dc5874 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7731e77a70a0b1a93d247f89aef77e7 |
| publicationDate | 2021-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2807890-T3 |
| titleOfInvention | Sialic acid analogs |
| abstract | A compound having the structural formula (Ia): ** (See formula) ** or a pharmaceutically acceptable salt or solvate thereof; wherein: R2, R4 and R6 are independently hydrogen or a structural unit selected from structural formula (a), (b), (c), (f) and (g): ** (See formula) ** R1 is hydrogen or structural formula (f); X is oxygen or sulfur; L1 and L2 are each independently a covalent bond, -O- or -NR10a-; R10a is hydrogen or optionally substituted alkyl; R1a and R2a are each independently hydrogen, optionally substituted alkyl, optionally substituted heteroalkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, -Xa-C (O) -O-R11a, or -Xa-OC (O) -O-R11a; Xa is optionally substituted alkylene; each R11a is independently hydrogen, optionally substituted alkyl, or optionally substituted heteroalkyl; R3a, together with the structural unit -OC (O) - to which it is attached, form a monopeptidyl or dipeptidyl group; each R8a and R9a is independently hydrogen or optionally substituted alkyl; m is 1 or 2; and Z is hydrogen, C1-C6 alkyl, an amide group, a lactam group, an ester group, a lactone group, a urea group, a cyclic urea group, a carbonate group, a cyclic carbonate group, a carbamate group, a cyclic carbamate, or a structural unit selected from (a), (b), (c) and (f); wherein, when R1 is hydrogen, R2 and R4 are hydrogen, and R6 has the structural formula (f). |
| priorityDate | 2011-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 248.